Greg Challener

Rheumatologist @ColumbiaMed | formerly @mghrheumatology, @MayoMN_IMRES, @umnmedschool, @dartmouth

[Greg Challener @ChallenerMD]

Associations Between Pre‐Existing Autoimmunity and Chimeric Antigen Receptor T Cell Therapy Toxicity for Cancer Treatment - Challener - 2025 - ACR Open Rheumatology - Wiley Online Library https://t.co/Lu5JjIG3a6

[Minna Kohler, MD, RhMSUS @minnakohlermd]

Delighted to share our oncorheumatology experience in using musculoskeletal ultrasound for the diagnosis & management of immune checkpoint inhibitors https://t.co/XY5LREz1Oa #rheumatology #oncology @janethyinhmd @ChallenerMD

[MGH Rheumatology @MGHrheumatology]

Dr. Greg Challener presented the Impact of Tirzepatide on MSK pain at #EULAR2025 https://t.co/tbOl39SNnT @ChallenerMD @natalie_mccor @minnakohlermd @janethyinhmd @ChioYokoseMD @AprilJorgeMD #hyonchoimd #obesity #glp1 #jointpain #mskpain #MedX

[MGH Rheumatology @MGHrheumatology]

.@MassGeneralMDs Oncorheumatology team presents abstract at #ASCO25 Clinical phenotype & management of MSK #irAEs treated with ICIs ✅️https://t.co/SQn0A8ztgG @ChallenerMD @janethyinhmd @minnakohlermd @kreynoldsMD @ASPIRE_CoP @ASCO @MGHCancerCenter @MGH_MSUS

[Greg Challener @ChallenerMD]

@RheumNow Chest CT with myositis panel. Inverse Gottron's sign is pathognomonic for anti-MDA5 DM

[Minna Kohler, MD, RhMSUS @minnakohlermd]

Immune Checkpoint Inhibitor pts tx'd w/sulfasalazine (SSZ) ➡️ high rates of AEs/hypersensitivity rxns ➡️ SSZ discontinuation. Observed rate of AEs > in SSZ-treated RA pts @ChallenerMD @janethyinhmd
@ChioYokoseMD #hyonchoimd #Oncology https://t.co/zcnof3qlGZ @sitcancer

[MGH Rheumatology MSK Ultrasound Program @MGH_MSUS]

Musculoskeletal #Ultrasound Characteristics of Checkpoint Inhibitor-Associated Inflammatory #Arthritis
https://t.co/txrS8s0U3y @NasrallahMazen @ChallenerMD @markmatzamd @kreynoldsMD #SaraSchoenfeldMD #DonaldLawrenceMD #RyanSullivanMD @minnakohlermd @MGHCancerCenter #Oncology